Arkolith/Insider Trading/MYOV/Form 4

Sumitomo Pharma Co., Ltd.

10% OwnerMyovant Sciences Ltd. (MYOV) · full profile →Form 4 · filed Mar 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2023Other(J)4.2M—$045.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2023Other(J)1—$01

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-007110) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML